Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration

DSpace/Manakin Repository

Show simple item record Swan, Davina Long, Jean Carr, Olivia Lambert, John Cullen, Walter et al. 2018-05-14T09:47:54Z 2018-05-14T09:47:54Z 2010 Mary Ann Liebert Publications en 2010-12-07
dc.identifier.citation AIDS Patient Care and STDs en
dc.description.abstract Hepatitis C (HCV) infection is common among injecting drug users (IDUs), yet accessing of HCV care, particularly HCV treatment, is suboptimal. There has been little in-depth study of IDUs experiences of what enables or prevents them engaging at every level of HCV care, including testing, follow-up, management and treatment processes. This qualitative study aimed to explore these issues with current and former IDUs in the greater Dublin area, Ireland. From September 2007 to September 2008 in-depth interviews were conducted with 36 service-users across a range of primary and secondary care services, including: two addiction clinics, a general practice, a community drop-in center, two hepatology clinics, and an infectious diseases clinic. Interviews were analyzed using a grounded theory approach. Barriers to HCV care included perceptions of HCV infection as relatively benign, fear of investigations and treatment, and feeling well. Perceptions were shaped by the discourse about HCV and "horror stories'' about the liver biopsy and treatment within their peer networks. Difficulties accessing HCV care included limited knowledge of testing sites, not being referred for specialist investigations and ineligibility for treatment. Employment, education, and addiction were priorities that competed with HCV care. Relationships with health care providers influenced engagement with care: Trust in providers, concern for the service-user, and continuity of care fostered engagement. Education on HCV infection, investigations, and treatment altered perceptions. Becoming symptomatic, responsibilities for children, and wanting to move on from drug use motivated HCV treatment. In conclusion, IDUs face multiple barriers to HCV care. A range of facilitators were identified that could inform future interventions. en
dc.description.sponsorship Health Research Board en
dc.language.iso en en
dc.publisher Mary Ann Liebert en
dc.rights Final publication is available from Mary Ann Liebert, Inc., publishers en
dc.subject HCV infection en
dc.subject Women en
dc.subject Risk en
dc.subject HIV en
dc.subject Prevalence en
dc.title Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration en
dc.type Journal Article en
dc.status Peer reviewed en
dc.identifier.volume 24 en
dc.identifier.issue 12 en
dc.identifier.startpage 753 en
dc.identifier.endpage 762 en
dc.identifier.doi 10.1089/apc.2010.0142
dc.neeo.contributor Swan|Davina|aut|
dc.neeo.contributor Long|Jean|aut|
dc.neeo.contributor Carr|Olivia|aut|
dc.neeo.contributor Lambert|John|aut|
dc.neeo.contributor Cullen|Walter|aut|
dc.neeo.contributor et al.||aut|
dc.internal.rmsid 241501820 2017-09-15T18:20:53Z

This item appears in the following Collection(s)

Show simple item record

This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

If you are a publisher or author and have copyright concerns for any item, please email and the item will be withdrawn immediately. The author or person responsible for depositing the article will be contacted within one business day.

Search Research Repository

Advanced Search